Composite diffuse large B-cell and peripheral T-cell lymphoma with T-helper phenotype treated with both rituximab and brentuximab vedotin

Saved in:
Bibliographic Details
Published in:Annals of hematology 2021-11, Vol.100 (11), p.2873-2875
Main Authors: Ohya, Kouichi, Okuyama, Shuhei, Ogata, Shin-ya, Maeda, Kunihiko, Yamada, Kyohei, Ohshima, Kouichi, Tajima, Katsushi
Format: Article
Language:English
Subjects:
Aged, 80 and over
Antineoplastic Agents, Immunological - therapeutic use
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Brentuximab Vedotin - therapeutic use
Female
Hematology
Humans
Letter to the Editor
Lymphoma, Large B-Cell, Diffuse - complications
Lymphoma, Large B-Cell, Diffuse - drug therapy
Lymphoma, T-Cell, Peripheral - complications
Lymphoma, T-Cell, Peripheral - drug therapy
Medicine
Medicine & Public Health
Oncology
Rituximab - therapeutic use
T-Lymphocytes, Helper-Inducer - drug effects
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0939-5555
1432-0584
DOI:10.1007/s00277-021-04633-6